Kay Mark A
Insider CIK 1752537 · LOGC Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| LOGC LogicBio Therapeutics, Inc | D To issuer deriv | 2022-11-16 | 2022-11-17 | 12,500 | — | $0 | 0 | SEC↗ |
| LOGC LogicBio Therapeutics, Inc | D To issuer deriv | 2022-11-16 | 2022-11-17 | 140,615 | — | $0 | 0 | SEC↗ |
| LOGC LogicBio Therapeutics, Inc | D To issuer deriv | 2022-11-16 | 2022-11-17 | 13,089 | — | $0 | 0 | SEC↗ |
| LOGC LogicBio Therapeutics, Inc | D To issuer | 2022-11-16 | 2022-11-17 | 784,557 | — | $0 | 0 | SEC↗ |
| LOGC LogicBio Therapeutics, Inc | A Award deriv | 2022-06-17 | 2022-06-21 | 12,500 | — | $0 | 12,500 | SEC↗ |
| LOGC LogicBio Therapeutics, Inc | A Award deriv | 2021-06-18 | 2021-06-21 | 5,000 | — | $0 | 5,000 | SEC↗ |
| LOGC LogicBio Therapeutics, Inc | A Award deriv | 2021-06-11 | 2021-06-14 | 12,500 | — | $0 | 12,500 | SEC↗ |
| LOGC LogicBio Therapeutics, Inc | M Exercise deriv | 2021-01-01 | 2021-01-04 | 2,199 | — | $0 | 0 | SEC↗ |
| LOGC LogicBio Therapeutics, Inc | M Exercise | 2021-01-01 | 2021-01-04 | 2,199 | — | $0 | 2,199 | SEC↗ |
| LOGC LogicBio Therapeutics, Inc | A Award deriv | 2020-06-19 | 2020-06-23 | 2,199 | — | $0 | 2,199 | SEC↗ |
| LOGC LogicBio Therapeutics, Inc | A Award deriv | 2020-06-19 | 2020-06-23 | 10,000 | — | $0 | 10,000 | SEC↗ |
| LOGC LogicBio Therapeutics, Inc | A Award deriv | 2019-12-19 | 2019-12-23 | 10,869 | — | $0 | 10,869 | SEC↗ |
| LOGC LogicBio Therapeutics, Inc | A Award deriv | 2018-10-18 | 2018-10-22 | 24,102 | — | $0 | 24,102 | SEC↗ |